Vigilant Biosciences pulls in $5.5 mln
Miami-based Vigilant Biosciences Inc, a provider of early cancer detection solutions, has received $5.5 million in Series B funding. The investors included White Owl Capital Partners, venVelo and the Florida Institute for the Commercialization of Public Research.
24 February 2015•4 mins read
